@article{10803,
  keywords = {Female, Humans, *Breast Neoplasms/chemically induced/epidemiology, Case-Control Studies, Contraceptives, Oral, Hormonal/adverse effects, Logistic Models, *Progestins/adverse effects, United Kingdom/epidemiology, Adult, Middle Aged},
  author = {D. Fitzpatrick and K. Pirie and G. Reeves and J. Green and V. Beral},
  title = {Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis},
  year = {2023},
  journal = {PLoS Med},
  volume = {20},
  edition = {2023/03/22},
  number = {3},
  pages = {e1004188},
  isbn = {1549-1277 (Print)
1549-1277},
  doi = {10.1371/journal.pmed.1004188},
  note = {1549-1676
Fitzpatrick, Danielle
Orcid: 0000-0003-0616-6282
Pirie, Kirstin
Orcid: 0000-0002-0561-4904
Reeves, Gillian
Green, Jane
Beral, Valerie
C570/A16491/CRUK_/Cancer Research UK/United Kingdom
A29186/CRUK_/Cancer Research UK/United Kingdom
MR/K02700X/1/MRC_/Medical Research Council/United Kingdom
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
United States
PLoS Med. 2023 Mar 21;20(3):e1004188. doi: 10.1371/journal.pmed.1004188. eCollection 2023 Mar.},
  language = {eng},
}